Chad Moles is the Chief Science Officer (CSO) and cofounder of Humane Genomics, a digital biotech company developing an AI platform to design and build synthetic viruses as personalized cancer therapies on-demand, starting with dogs. He is a member of Genome Project-write, an international research project focused on driving the development of new technologies for whole-genome synthesis and engineering. Most recently, he was selected as a Biosecurity and Synthetic Biology Fellow by the Johns Hopkins Center for Health Security. Chad earned a B.S. in Public Health from Tulane University, followed by a fellowship in regenerative medicine at Baylor College of Medicine, and a M.A. in Biotechnology from Columbia University. During his graduate studies, Chad provided bioinformatics support for the Synthetic Yeast Genome Project (Sc2.0), and completed an internship with Neochromosome, a biotech startup focused on the design, build, and optimization of synthetic chromosomes for genome engineering. Under the supervision of Dr. Jef Boeke, his thesis focused on using synthetic genome engineering to develop next-generation vaccines and therapeutics.